Preclinical LVDD progression over 5 years resulted in a small proportion of incident HF and an increase in median NT-proBNP from 71 to 100 pg/mL.
Cohort
In patients with preclinical LVDD, high blood pressure and decreased kidney function are associated with increasing NT-proBNP levels over 5 years, though incident HF is rare.
BACKGROUND: The progression of left ventricular diastolic dysfunction (LVDD) over time may lead to the development of heart failure with preserved ejection fraction (HFpEF). HFpEF is twice as common in women compared with men; however, the sex-specific progression from LVDD towards HFpEF is poorly described. Therefore, we aim to evaluate changes over time in markers of LVDD severity and HFpEF in women and men with preclinical LVDD. METHODS AND RESULTS: and median NT-proBNP plasma levels increased from 71 (IQR: 44-120) to 100 (IQR: 51-157) pg/mL. In women, a higher systolic and in men a higher diastolic blood pressure were associated with an increase in NT-proBNP plasma levels over time. Lower eGFR levels were related to increased NT-proBNP plasma levels over time in both men and women. CONCLUSIONS: Our study demonstrates that only a small proportion of women and men with preclinical LVDD develop incident HF over a roughly 5-year follow-up period. High blood pressure and decreased kidney function were associated with higher levels of NT-proBNP. This highlights the need to further explore cardiorenal protection as a method to prevent HFpEF.
Ommen et al. (Thu,) conducted a cohort in Preclinical LVDD. Observational follow-up was evaluated on Changes over time in markers of LVDD severity and incident HFpEF. Preclinical LVDD progression over 5 years resulted in a small proportion of incident HF and an increase in median NT-proBNP from 71 to 100 pg/mL.